Abridge structures and summarizes information from the most important signals in healthcare - spoken conversations. Abridge's technology is powered by industry-leading R&D, as evidenced by their depth of peer-reviewed publications in medical conversation AI and user experience design. The company's audio and ambient AI-centered solutions help clinicians practice at the top of their license and patients stay on top of their health. Whether an appointment takes place in-person or via telemedicine, Abridge captures and documents the conversation to meet the needs of providers, patients, and enterprises.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/11/22 | $12,500,000 | Series A-1 |
Bessemer Venture Partners Pillar VC Union Square Ventures UPMC Enterprise Whistler Capital Wittington Ventures  Yoshua Bengio | undisclosed |
| 02/23/24 | $150,000,000 | Series C |
Bessemer Venture Partners CVS Health Ventures IVP Kaiser Permanente Ventures Lightspeed Venture Partners Mass General Brigham Ventures Redpoint Ventures Spark Capital Union Square Ventures Wittington Ventures | undisclosed |
